Archive - August 2018
Daily Brief: Cellectis gains Novartis scientist, EU label updates for Janssen and Otsuka
Developing Capsules for DPIs
Mallinckrodt doses first patient in muscular dystrophy trial
Do you have a passion for medical information?
EMA grants PRIME status for Roche Huntington’s drug
AZ and MSD get orphan designation for neurofibromatosis drug
Almirall buys Allergan’s US dermatology portfolio for $650 million
China’s BeiGene raises $903m from Hong Kong IPO
